More than 200 people in nine states have reported bleeding or other symptoms associated with exposure to synthetic cannabinoid products containing an anticoagulant agent, including five who died, the Centers for Disease Control and Prevention reported Friday in an update on an outbreak that began in March. Most of the cases were in Illinois, and the rest in Maryland, Florida, Indiana, Kentucky, Missouri, Pennsylvania, Virginia and Wisconsin. Nearly all of the patients have tested positive for brodifacoum, a vitamin K antagonist anticoagulant, which public health officials believe may have been mixed with synthetic cannabinoid products, commonly referred to as synthetic marijuana, K2 or Spice. CDC said health care providers should screen patients presenting with unexplained bleeding and a possible history of synthetic cannabinoid for vitamin K-dependent antagonist coagulopathy, and report possible cases to their local health department, among other recommendations.

Related News Articles

Headline
The Centers for Medicare…
Headline
A coalition of 29 health care and public health organizations, including the AHA, today urged Congress to pass the Pandemic and All-Hazards Preparedness…
Headline
The Department of Health and Human Services’ Office for Civil Rights yesterday issued recommendations and resources to help first responders provide language…
Headline
Health and Human Services Secretary Alex Azar yesterday declared a public health emergency in Alaska due to Friday’s earthquake, and waived certain…
Headline
All Alaska hospitals remained opened during Friday’s earthquake and damage was minimal, according to the Alaska State Hospital & Nursing Home Association.
Headline
In the wake of Monday’s shooting a